Cargando…
New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
Autores principales: | Villalta, Danilo, Moratto, Anna, Salgarolo, Valeria, Re, Mirella Da, Giacomello, Roberto, Malipiero, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368222/ https://www.ncbi.nlm.nih.gov/pubmed/34374358 http://dx.doi.org/10.3343/alm.2022.42.1.113 |
Ejemplares similares
-
Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
por: Villalta, Danilo, et al.
Publicado: (2021) -
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
por: Malipiero, Giacomo, et al.
Publicado: (2022) -
Answer to the letter of Lippi & Plebani entitled “Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal”
por: Malipiero, Giacomo, et al.
Publicado: (2022) -
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease
por: Malipiero, Giacomo, et al.
Publicado: (2021) -
Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease
por: Villalta, Danilo, et al.
Publicado: (2018)